Empower Advisory Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$368K Sell
4,248
-80
-2% -$7.66K ﹤0.01% 376
2025
Q4
$416K Sell
4,328
-238
-5% -$23.1K ﹤0.01% 359
2025
Q3
$435K Buy
4,566
+546
+14% +$50.2K ﹤0.01% 358
2025
Q2
$350K Sell
4,020
-228
-5% -$19.3K ﹤0.01% 375
2025
Q1
$382K Sell
4,248
-199
-4% -$17.8K ﹤0.01% 358
2024
Q4
$355K Buy
4,447
+231
+5% +$20K ﹤0.01% 372
2024
Q3
$380K Sell
4,216
-148
-3% -$12.4K ﹤0.01% 360
2024
Q2
$343K Sell
4,364
-989
-18% -$81.1K ﹤0.01% 370
2024
Q1
$467K Buy
5,353
+1,013
+23% +$86.5K ﹤0.01% 314
2023
Q4
$358K Buy
4,340
+538
+14% +$41K ﹤0.01% 353
2023
Q3
$298K Sell
3,802
-309
-8% -$25.9K ﹤0.01% 380
2023
Q2
$362K Buy
+4,111
New +$354K ﹤0.01% 353

Other funds holding MDT

Empower Advisory Group's MDT Position: Q1 2026 in Review

Empower Advisory Group reduced its Medtronic (MDT) stake by 1.8% in Q1 2026, selling an estimated $7.66K and leaving 4,248 shares worth $368K. The position accounts for ﹤0.01% of the portfolio, ranked #376.

Empower Advisory Group first reported a position in MDT in Q2 2023 and has held it in 12 quarters since. The position peaked at $467K in Q1 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Empower Advisory Group held 4,248 shares of Medtronic worth $368K as of Q1 2026.
  • Empower Advisory Group sold 80 Medtronic shares in Q1 2026, an estimated $7.66K.
  • Medtronic made up ﹤0.01% of Empower Advisory Group's portfolio in Q1 2026, its #376 holding.
  • Empower Advisory Group first reported a position in Medtronic in Q2 2023 and has held it in 12 quarters since.
  • Empower Advisory Group's Medtronic position peaked at $467K in Q1 2024.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Empower Advisory Group's 13F filing for Q1 2026, filed 14 May 2026.